Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(9):696; doi:10.1093/jnci/dji121
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schröder, F. H.
Right arrow Articles by Bangma, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schröder, F. H.
Right arrow Articles by Bangma, C. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

Fritz H. Schröder, Monique J. Roobol, Ronald A. M. Damhuis, Harry J. de Koning, Bert G. Blijenberg, Theo H. Van der Kwast, Wim J. Kirkels, Chris H. Bangma

Affiliations of authors: Department of Urology (FHS, MJR, WJK, CHB), Department of Public Health (HJdK), Department of Clinical Chemistry (BGB), and Department of Pathology (THVdK), Erasmus MC Rotterdam, The Netherlands; Comprehensive Cancer Center, Rotterdam, The Netherlands (RAMD)

Correspondence to: Fritz H. Schröder, MD, PhD, Department of Urology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands (e-mail: e.vandenberg@erasmusmc.nl).

The first 10% of the full text of this article appears below.

Four pilot studies were conducted in Rotterdam, The Netherlands, prior to the initiation of the European Randomized Study of Screening for Prostate Cancer (ERSPC). The main purpose of these studies was to establish the feasibility of randomization and of the testing procedures. The pilot studies were not part of the ERSPC, and they were not carried out according to a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
M. J. Roobol, A. Grenabo, F. H. Schroder, and J. Hugosson
Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam
J Natl Cancer Inst, September 5, 2007; 99(17): 1296 - 1303.
[Abstract] [Full Text] [PDF]

Home page
 cfpHome page
Y. Fradet
Should Canadians be offered systematic prostate cancer screening?: YES
Can Fam Physician, June 1, 2007; 53(6): 989 - 992.
[Full Text] [PDF]

Home page
 cfpHome page
Y. Fradet
Devrait-on offrir aux Canadiens le depistage systematique du cancer de la prostate?: OUI
Can Fam Physician, June 1, 2007; 53(6): 994 - 997.
[Full Text] [PDF]